HALO logo
halo search icon
PHO
Photocure ASA

PHO · Photocure ASA

56.10

NOK
-0.30 (-0.532%)
24/07/2026 12:00:00 AM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

NOK1.53B

PE

80.30

EV/EBITDA

12.8

DIV Yield

0%

Payout Ratio

0%

MQV Rating

5Very Weak

As at 24/07/2026 12:00:00 AM

Price Chart

Description

Photocure ASA engages in the development and commercialization of pharmaceutical products based on photodynamic technology. Its products include Metvix for nonmelanoma skin cancer, Hexvix/Cysview for better detection and management of bladder cancer, and Cevira which is a photodynamic drug-device combination product for non-surgical treatment of high-grade cervical dysplasia. The company operates through the Commercial Franchise and Development Portfolio segments. The Commercial Franchise segment includes the sale of Hexvix/Cysview in the U.S. and Europe and other sales from partners and other products. The Development Portfolio segment focuses on the development of pipeline products. The company was founded in 1997 and is headquartered in Oslo, Norway.

  • All-Companies
  • All-Consensus
  • Consensus Cheap
  • HALO 200
  • HALO All
  • HALO Balance Sheet
  • HALO Consensus Value
  • HALO Small
  • Recent Earnings downgrade

Key Fundamentals

EPS 3 yr Growth

-97.90%

EBITDA Margin

26.20%

Operating Cashflow

NOK44m

Free Cash Flow Return

7.20%

ROIC

-0.20%

Interest Coverage

5.60

Quick Ratio

3.10

Performance

52 weeks range

Low 50.5 - 79.8

Trade Value (12mth)

US$105,075.00

1 week

-2.08%

1 month

-5.69%

YTD

-21.56%

1 year

-8.59%

All time high

154.50

Additional Data

Shares Outstanding (Fully Diluted)

27m

HALO Sector

Healthcare

Next Company Report Date

24-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

NOK

Short Sell (% of issue)

0.00

Consensus

Lock Icon

Unlock full consensus

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Weak

Garp

Weak

Mqv Small

Very Weak

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Strong

Dividends

Very Weak

Quality

Capital Efficiency

Weak

Balance Sheet

Very Strong

Valuation

Lock Icon

Unlock full dataset

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

No announcements available.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial
Want to learn more?Frequently asked questions.
1
What is the current share price of Photocure ASA (PHO:OSL)?
Halo FAQ
The current share price of Photocure ASA (PHO:OSL) is NOKkr56.10.
2
What is the 52-week high share price for Photocure ASA (PHO:OSL)?
Halo FAQ
The 52-week high share price for Photocure ASA (PHO:OSL) is NOKkr79.80.
3
What is the 52-week low share price for Photocure ASA (PHO:OSL)?
Halo FAQ
The 52-week low share price for Photocure ASA (PHO:OSL) is NOKkr50.50.
4
What is the dividend yield for Photocure ASA (PHO:OSL)?
Halo FAQ
Photocure ASA (PHO:OSL) does not pay a dividend.
5
What was Photocure ASA (PHO:OSL) last dividend payment?
Halo FAQ
The last dividend payment of Photocure ASA (PHO:OSL) is NOKkr2.00.
6
What is the franking level for Photocure ASA (PHO:OSL)?
Halo FAQ
Photocure ASA (PHO:OSL) has a franking level of 0.00%.
7
In which sector is Photocure ASA (PHO:OSL) classified?
Halo FAQ
Photocure ASA (PHO:OSL) is classified in the Healthcare.
8
What is the price-to-earnings (P/E) ratio for Photocure ASA (PHO:OSL)?
Halo FAQ
The current P/E ratio for Photocure ASA (PHO:OSL) is 80.30.